Physician profile
Stephen Delatte
NPI 1245253194
$3,441.49
in general payments reported to CMS, 2019-2025
14 companies · $542 in 2025
The $542 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $102 · 2021: $95.68 · 2022: $400 · 2023: $553 · 2024: $914 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.73 |
| Long Term Medical Supply Or Device Loan | $326.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $765.20 | 2024-2025 | Daxxify |
| Galderma Laboratories, L.P. | $627.29 | 2019-2024 | Dysport |
| Abbvie INC. | $385.79 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $365.17 | 2019-2022 | |
| Integra Lifesciences Corporation | $361.28 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Tepha INC | $248.07 | 2019 | |
| Tela Bio, INC. | $153.24 | 2024 | Ovitex 2s |
| Davol INC. | $141.34 | 2022 | |
| Mentor Worldwide LLC | $133.88 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $131.27 | 2022 | |
| Baxter Healthcare | $39.54 | 2020 | |
| Getinge USA Sales, LLC | $36.53 | 2021 | |
| Ethicon US, LLC | $32.99 | 2023 | Vistaseal |
| Motiva USA, LLC | $19.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Delatte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.